Involvement of Androgen/Androgen Receptor Pathway in Fabry Disease
Novel therapies for the treatment of Fabry disease by using androgen/androgen receptor (AR) pathway-related molecules as biomarkers and use of approaches targeting androgen/AR pathway are presented herein. The involvement of aberrant androgen/AR pathway in Fabry disease has never been previously des...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English |
Published |
08.09.2011
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Novel therapies for the treatment of Fabry disease by using androgen/androgen receptor (AR) pathway-related molecules as biomarkers and use of approaches targeting androgen/AR pathway are presented herein. The involvement of aberrant androgen/AR pathway in Fabry disease has never been previously described. The present invention describes, (i) use of approaches that target androgen/AR pathway as therapeutic treatments for Fabry disease and (2) use of the levels of androgen/AR pathway-related molecules in body fluids or tissues as biomarkers for evaluation of disease progression and efficacy of treatments in Fabry patients. |
---|---|
Bibliography: | Application Number: US201113038293 |